Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SBG in chronic diabetic foot ulcers
NCT00804414Phase 3Completed
- Sponsor
- Biotec Pharmacon ASA
- Start
- Oct 2008
- Primary completion
- Aug 2009
- Modality
- Biologic, Polysaccharide
- Countries
- 1
01
Overview
A Phase 3 trial of beta-1,3/1,6-glucan in diabetic foot ulcer (DFU), sponsored by Biotec Pharmacon ASA. Started Oct 2008; status: completed.
02
Drugs
beta-1,3/1,6-glucan
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT00804414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00804414.